Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
7
×
medicaid
7
×
national blog main
life sciences
national top stories
boston blog main
boston top stories
clinical trials
johnson & johnson
national
new york blog main
new york top stories
seattle blog main
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle top stories
startups
texas blog main
texas top stories
biotech
cancer
fda
gene therapy
medicare
pfizer
roche
sanofi
What
roundup
alzheimer’s
bio
drug
gene
focus
therapy
access
according
account
aducanumab
advanced
age
ahead
aids
ambien
american
amyloid
angst
annual
asco
attendees
attention
baby
bagged
bigger
biggest
billions
biogen
biogen’s
biotech
boomers
brammer
budget
camp’s
cancer
capacity
car
cash
cell
Language
unset
Current search:
medicaid
×
deals
×
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
5 years ago
Tcare’s Software Aids People Who Live with, and Care for, Loved Ones
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More